Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sapan Shah, Dinesh Chaple, Sumit Arora, Subhash Yende, Chetan Mehta & Usha Nayak. (2022) Prospecting for Cressa cretica to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 40:12, pages 5643-5652.
Read now
Read now
Khaled Mosaad Elhusseiny, Fatma Abd-Elshahed Abd-Elhay & Mohamed Gomaa Kamel. (2020) Possible therapeutic agents for COVID-19: a comprehensive review. Expert Review of Anti-infective Therapy 18:10, pages 1005-1020.
Read now
Read now
Articles from other publishers (35)
Uzma Afreen, Ushna Afreen & Daraksha Bano. 2023. COVID-19: Origin, Impact and Management (Part 2). COVID-19: Origin, Impact and Management (Part 2)
1
21
.
V. S. Kulkarni, V. Alagarsamy, V. R. Solomon, P. A. Jose & S. Murugesan. (2023) Drug Repurposing: An Effective Tool in Modern Drug Discovery. Russian Journal of Bioorganic Chemistry 49:2, pages 157-166.
Crossref
Crossref
Poonam Sen & Harpreet Kaur. (2023) In silico transcriptional analysis of asymptomatic and severe COVID-19 patients reveals the susceptibility of severe patients to other comorbidities and non-viral pathological conditions. Human Gene 35, pages 201135.
Crossref
Crossref
Ghalia Shamlan & Fadilah Sfouq Aleanizy. (2022) Knowledge and behaviors of using vitamin D to boost immunity against COVID-19 pandemic: A cross-sectional study in Saudi Arabia. Medicine 101:48, pages e31949.
Crossref
Crossref
Md. Parvez Mosharaf, Md. Kaderi Kibria, Md. Bayazid Hossen, Md. Ariful Islam, Md. Selim Reza, Rashidul Alam Mahumud, Khorshed Alam, Jeff Gow & Md. Nurul Haque Mollah. (2022) Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing. Vaccines 10:8, pages 1248.
Crossref
Crossref
Álvaro Avezum, Gustavo B F Oliveira, Haliton Oliveira, Rosa C Lucchetta, Valéria F A Pereira, André L Dabarian, Ricardo D´O Vieira, Daniel V Silva, Adrian P M Kormann, Alexandre P Tognon, Ricardo De Gasperi, Mauro E Hernandes, Audes D M Feitosa, Agnaldo Piscopo, André S Souza, Carlos H Miguel, Vinicius O Nogueira, César Minelli, Carlos C Magalhães, Karen M L Morejon, Letícia S Bicudo, Germano E C Souza, Marco A M Gomes, José J F Raposo Fo, Alexandre V Schwarzbold, Alexandre Zilli, Roberto B Amazonas, Frederico R Moreira, Lucas B O Alves, Silvia R L Assis, Precil D M M Neves, Jessica Y Matuoka, Icaro Boszczowski, Daniela G M Catarino, Viviane C Veiga, Luciano C P Azevedo, Regis G Rosa, Renato D Lopes, Alexandre B Cavalcanti & Otavio Berwanger. (2022) Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE – Coalition V): A double-blind, multicentre, randomised, controlled trial. The Lancet Regional Health - Americas 11, pages 100243.
Crossref
Crossref
Jun-Lin Yu, Qing-Qing Dai & Guo-Bo Li. (2022) Deep learning in target prediction and drug repositioning: Recent advances and challenges. Drug Discovery Today 27:7, pages 1796-1814.
Crossref
Crossref
Luis Ignacio Garegnani, Eva Madrid & Nicolás Meza. (2022) Misleading clinical evidence and systematic reviews on ivermectin for COVID-19. BMJ Evidence-Based Medicine 27:3, pages 156-158.
Crossref
Crossref
Shiwei Jiang & Hongwei Hou. (2022) A Secure Artificial Intelligence-Enabled Critical Sars Crisis Management Using Random Sigmoidal Artificial Neural Networks. Frontiers in Public Health 10.
Crossref
Crossref
Ebenezer Olatunde FarombiIfeoluwa Oluleke AwogbindinTemitope H. FarombiCynthia Nwamaka IkejiAdebisi A. AdebisiIsaac A. AdedaraOkezie I. Aruoma. (2022)
Possible role of Kolaviron, a
Garcinia kola
bioflavonoid in inflammation associated COVID-19 infection
. American Journal of Biopharmacy and Pharmaceutical Sciences 2, pages 3.
Crossref
Crossref
Willis Gwenzi, Rangabhashiyam Selvasembian, Nnanake-Abasi O. Offiong, Alaa El Din Mahmoud, Edmond Sanganyado & Joyabrata Mal. (2022) COVID-19 drugs in aquatic systems: a review. Environmental Chemistry Letters 20:2, pages 1275-1294.
Crossref
Crossref
Md. Parvez Mosharaf, Md. Selim Reza, Md. Kaderi Kibria, Fee Faysal Ahmed, Md. Hadiul Kabir, Sohel Hasan & Md. Nurul Haque Mollah. (2022) Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing. Scientific Reports 12:1.
Crossref
Crossref
Noha Samir Taibe, Maimona A. Kord, Mohamed Ahmed Badawy, Iart Luca Shytaj & Mahmoud M. Elhefnawi. (2022) Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment. Therapeutic Advances in Respiratory Disease 16, pages 175346662211327.
Crossref
Crossref
L. C. Mendes, J. Ávila & A. A. Pereira. 2022. XXVII Brazilian Congress on Biomedical Engineering. XXVII Brazilian Congress on Biomedical Engineering
2111
2116
.
Vladimir Vimberg. (2021) Teicoplanin—A New Use for an Old Drug in the COVID-19 Era?. Pharmaceuticals 14:12, pages 1227.
Crossref
Crossref
Hindustan Abdul AhadChinthaginjala HaranathSyed RahamathullaSyed ShaikshavaliSyed AyeshaSyed Azmathulla. (2021) Concoct Children to Combat the Third Wave of COVID-19. Asian Journal of Research in Chemistry, pages 455-458.
Crossref
Crossref
Nikita Khanna, Sandip V. Pawar & Anil Kumar. (2021) A Review on Repurposed Drugs and Vaccine Trials for Combating SARS CoV-2. Current Drug Research Reviews 13:3, pages 203-221.
Crossref
Crossref
Asmi Citra Malina A.R. Tassakka, Ophirtus Sumule, Muhammad Nasrum Massi, Sulfahri, Marianti Manggau, Israini Wiyulanda Iskandar, Jamaluddin Fitrah Alam, Andi Dian Permana & Lawrence M. Liao. (2021) Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) – A computational study. Arabian Journal of Chemistry 14:11, pages 103393.
Crossref
Crossref
Luana Calabrò, Giulia Rossi, Alessia Covre, Aldo Morra & Michele Maio. (2021) COVID and Lung Cancer. Current Oncology Reports 23:11.
Crossref
Crossref
Ilona Bereczki, Henrietta Papp, Anett Kuczmog, Mónika Madai, Veronika Nagy, Attila Agócs, Gyula Batta, Márton Milánkovits, Eszter Ostorházi, Ana Mitrović, Janko Kos, Áron Zsigmond, István Hajdú, Zsolt Lőrincz, Dávid Bajusz, György Miklós Keserű, Jan Hodek, Jan Weber, Ferenc Jakab, Pál Herczegh & Anikó Borbás. (2021) Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication. Pharmaceuticals 14:11, pages 1111.
Crossref
Crossref
Yen-Hung Wu, I-Jeng Yeh, Nam Nhut Phan, Meng-Chi Yen, Jui-Hsiang Hung, Chung-Chieh Chiao, Chien-Fu Chen, Zhengda Sun, Hui-Ping Hsu, Chih-Yang Wang & Ming-Derg Lai. (2021) Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells. Journal of Microbiology, Immunology and Infection 54:5, pages 845-857.
Crossref
Crossref
Youssif M. Ali, Matteo Ferrari, Nicholas J. Lynch, Sadam Yaseen, Thomas Dudler, Sasha Gragerov, Gregory Demopulos, Jonathan L. Heeney & Wilhelm J. Schwaeble. (2021) Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins. Frontiers in Immunology 12.
Crossref
Crossref
Osama A. Badary. (2021) Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs. The Pharmacogenomics Journal 21:3, pages 275-284.
Crossref
Crossref
Mona Sadat Mirtaleb, Amir Hossein Mirtaleb, Hassan Nosrati, Jalal Heshmatnia, Reza Falak & Reza Zolfaghari Emameh. (2021) Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy. Biomedicine & Pharmacotherapy 138, pages 111518.
Crossref
Crossref
Kevin McCoy, Sateesh Gudapati, Lawrence He, Elaina Horlander, David Kartchner, Soham Kulkarni, Nidhi Mehra, Jayant Prakash, Helena Thenot, Sri Vivek Vanga, Abigail Wagner, Brandon White & Cassie S. Mitchell. (2021) Biomedical Text Link Prediction for Drug Discovery: A Case Study with COVID-19. Pharmaceutics 13:6, pages 794.
Crossref
Crossref
Niraj Kumar Jha, Charu Sharma, Hebaallah Mamdouh Hashiesh, Seenipandi Arunachalam, MF Nagoor Meeran, Hayate Javed, Chandragouda R. Patil, Sameer N. Goyal & Shreesh Ojha. (2021) β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Frontiers in Pharmacology 12.
Crossref
Crossref
Anna Clara Cachoni, Micael Borges Cadari, Augusto Alberto Foggiato, Juliana Zorzi Coléte, João Lopes Toledo Neto, Fabrício José Jassi & Douglas Fernandes da Silva. (2021) Biosafety and action in front of COVID-19. International Journal for Innovation Education and Research 9:4, pages 129-141.
Crossref
Crossref
Kenneth Lundstrom. (2021) Translational Virology in the Age of Pandemics. Frontiers in Virology 1.
Crossref
Crossref
Peter Manu. (2021) Ivermectin Research Should Not Be Used to Promote Vaccine Opposition. American Journal of Therapeutics 28:6, pages e680-e680.
Crossref
Crossref
Maywan Hariono, Pandu Hariyono, Rini Dwiastuti, Wahyuning Setyani, Muhammad Yusuf, Nurul Salin & Habibah Wahab. (2021) Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies. Results in Chemistry 3, pages 100195.
Crossref
Crossref
Caio P. Gomes, Danilo E. Fernandes, Fernanda Casimiro, Gustavo F. da Mata, Michelle T. Passos, Patricia Varela, Gianna Mastroianni-Kirsztajn & João Bosco Pesquero. (2020) Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Flavio A. Cadegiani. (2020) Repurposing existing drugs for COVID-19: an endocrinology perspective. BMC Endocrine Disorders 20:1.
Crossref
Crossref
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters & Andrea L. DiCarlo. (2020) Commonalities Between COVID-19 and Radiation Injury. Radiation Research 195:1.
Crossref
Crossref
Md. Shafiul Hossen, Md Abdul Barek, Nusrat Jahan & Mohammad Safiqul Islam. (2020) A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges. SN Comprehensive Clinical Medicine 2:10, pages 1777-1789.
Crossref
Crossref
Swapnil Morande & Veena Tewari. (2020) Technology Management for Accelerated Recovery during COVID-19. SEISENSE Journal of Management 3:5, pages 33-53.
Crossref
Crossref